These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9597561)

  • 1. Multiple-dose pharmacokinetics and pharmacodynamics of OROS and immediate-release amitriptyline hydrochloride formulations.
    Gupta SK; Shah J; Guinta D; Hwang S
    J Clin Pharmacol; 1998 Jan; 38(1):60-7. PubMed ID: 9597561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.
    Gupta SK; Shah JC; Hwang SS
    Br J Clin Pharmacol; 1999 Jul; 48(1):71-8. PubMed ID: 10383563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride.
    Sathyan G; Chancellor MB; Gupta SK
    Br J Clin Pharmacol; 2001 Oct; 52(4):409-17. PubMed ID: 11678784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
    Darwish M; Hellriegel ET
    Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation.
    Modi NB; Lindemulder B; Gupta SK
    J Clin Pharmacol; 2000 Apr; 40(4):379-88. PubMed ID: 10761165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bioequivalence of a new amitriptyline tablet formulation in comparison with a reference preparation].
    Metzner JE; Buchberger D; Dilger C; Läuter J; Schmidt U
    Arzneimittelforschung; 1998 Nov; 48(11):1072-8. PubMed ID: 9850427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
    Reiz JL; Donnelly GA; Michalko K
    Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
    Sennef C; Timmer CJ; Sitsen JM
    Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics.
    Wong SL; Cavanaugh J; Shi H; Awni WM; Granneman GR
    Clin Pharmacol Ther; 1996 Jul; 60(1):48-53. PubMed ID: 8689811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.
    Drover DR; Angst MS; Valle M; Ramaswamy B; Naidu S; Stanski DR; Verotta D
    Anesthesiology; 2002 Oct; 97(4):827-36. PubMed ID: 12357147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Average parameters in bioavailability studies: an application to slow-release amitriptyline formulation.
    Fagiolino P; Vázquez M; Savio E; Domínguez L; Aiache JM; Beyssac E
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):160-5. PubMed ID: 9725475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive bladder.
    Preik M; Albrecht D; O'Connell M; Hampel C; Anderson R
    BJU Int; 2004 Oct; 94(6):821-7. PubMed ID: 15476516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of oral amitriptyline in horses.
    Recchi L; Alvariza S; Benech A; Ruiz N; José Estradé M; Suarez G; Crosignani N
    J Vet Pharmacol Ther; 2020 Jul; 43(4):381-384. PubMed ID: 32339314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
    Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
    Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential.
    Spencer TJ; Biederman J; Martin JM; Moorehead TM; Mirto T; Clarke A; Batchelder H; Faraone SV
    Postgrad Med; 2012 Jan; 124(1):166-73. PubMed ID: 22314126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.